2018
DOI: 10.1159/000491497
|View full text |Cite
|
Sign up to set email alerts
|

Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application

Abstract: Highly antibiotic resistant, microbial communities, referred to as biofilms, cause various life-threatening infections in humans. At least two-thirds of all clinical infections are biofilm associated, and antibiotic therapy regularly fails to cure patients. Anti-biofilm peptides represent a promising approach to treat these infections by targeting biofilm-specific characteristics such as highly conserved regulatory mechanisms. They are being considered for clinical application and we discuss here key factors i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
82
0
2

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 91 publications
(86 citation statements)
references
References 72 publications
1
82
0
2
Order By: Relevance
“…This is similar to LL-37 which could also inhibit P. aeruginosa biofilm formation at sub-MIC [ 31 ]. The inhibition of biofilm by AMPs has been shown to be the result of stimulating twitching motility, influencing quorum sensing or degrading signaling molecules, such as ppGpp [ 32 , 33 ], or decreasing the expression of polysaccharide-intercellular adhesin genes [ 34 ]. The mechanism of action of melimine and Mel4 inhibiting biofilms of P. aeruginosa appeared to be very similar to their mode of action on P. aeruginosa cells in suspension [ 20 ], that is disrupting cell membranes resulting in release in intracellular contents.…”
Section: Discussionmentioning
confidence: 99%
“…This is similar to LL-37 which could also inhibit P. aeruginosa biofilm formation at sub-MIC [ 31 ]. The inhibition of biofilm by AMPs has been shown to be the result of stimulating twitching motility, influencing quorum sensing or degrading signaling molecules, such as ppGpp [ 32 , 33 ], or decreasing the expression of polysaccharide-intercellular adhesin genes [ 34 ]. The mechanism of action of melimine and Mel4 inhibiting biofilms of P. aeruginosa appeared to be very similar to their mode of action on P. aeruginosa cells in suspension [ 20 ], that is disrupting cell membranes resulting in release in intracellular contents.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, persister cells existing within a biofilm are metabolically inactive, so they pose a serious challenge for conventional antibiotics (Jorge et al, 2012;Shahrour et al, 2019). For a little more than a decade, AMPs have been acknowledged as a promising source of antibiofilm agents as well as of antibacterials, although only a small fraction of identified AMPs have been adequately studied in this particular aspect to date (Dostert et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Tyrothricin, a nonribosomally produced antimicrobial peptide (AMP) complex produced by the soil‐bacterium Brevibacillus parabrevis , was the first antibiotic preparation to be used in clinical practices (topical applications) but was soon replaced by penicillin . With pathogens displaying resistance to many of the existing drugs, AMPs and specifically nonribosomally produced AMPs are now reconsidered as potential antibiotics because of their broad spectrum of activity against bacteria, fungi, parasites, and certain viruses . Furthermore, the rapid antimicrobial action of AMPs and their ability to affect multiple targets decrease the likelihood of resistance developing against them …”
Section: Introductionmentioning
confidence: 99%